MentalHeal
Santiago Ini
santiagoini@nullyahoo.com
+972-543342669
MentalHeal is developing a novel oral antipsychotic drug, PGW-5, for the treatment of Schizophrenia and Bipolar disorder. Schizophrenia is a chronic, debilitating disease with significant morbidity and mortality that often requires antipsychotic pharmacotherapy for life. Current therapy today approach only the positives symptoms such Delusions, Hallucinations, Disorganized speech and Catatonia inducing serious side effects: extrapyramidal symptoms (move disorders) and metabolic side effect, such weight gain.
Unlike existent treatments, PGW-5 is able to treat the positives can treat Positive, Negative (social withdrawn and mood disorders) symptoms and cognitive deficits of Schizophrenia without inducing side effects.
Get more BANG for your BUCK at industry events.
Aneeva's Event Optimization Service helps you drive sales and maximize ROI from industry events via pre-set sales meetings with targeted customers.